MedTrace Logo

GALNT4 in Patients With Acute Coronary Syndrome

NCT03335514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-03-19

No results posted yet for this study

Summary

The expression of GALNT4 in blood with acute coronary syndrome

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

expression of GALNT4

Blood is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture and the total RNA was extracted from blood.Realtime PCR was performed to measure the expression of GALNT4.

Sponsors & Collaborators

  • The First Affiliated Hospital of Dalian Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335514 on ClinicalTrials.gov